This topic contains a solution. Click here to go to the answer

Author Question: Which test should be included when distinguishing between diffuse large B-cell lymphoma and blastic ... (Read 14 times)

Jipu 123

  • Hero Member
  • *****
  • Posts: 569
Which test should be included when distinguishing between diffuse large B-cell lymphoma and blastic mantle cell lymphoma?
 
  a. CD20
  b. Light chain analysis
  c. Cyclin-D1 stain
  d. IgM heavy chain analysis

Question 2

Large cells with abundant, intensely basophilic cytoplasm with prominent cytoplasmic vacuolization are identified on a peripheral smear. Multiple basophilic nucleoli are present.
 
  A starry sky appearance is seen with fields of basophilic leukemic blasts with benign macrophages that have ingested tumor cells. What leukemia should be suspected with this morphology?
 
  a. Acute undifferentiated leukemia
  b. Acute lymphoblastic leukemiaBurkitt-type
  c. Acute leukemia with lineage heterogeneity
  d. Precursor T-cell leukemia



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ttt030911

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

Correct Answer: C

Answer to Question 2

Correct Answer: B




Jipu 123

  • Member
  • Posts: 569
Reply 2 on: Jun 25, 2018
Gracias!


milbourne11

  • Member
  • Posts: 322
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

The ratio of hydrogen atoms to oxygen in water (H2O) is 2:1.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library